Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Durant

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Journal of Computer-Aided Molecular Design|February 1, 1996
Molecular modelling and conformational analysis of a GABAB antagonistB Pirard, F Durant
Neurobiology (Budapest, Hungary)|September 29, 2000
Structural approach of human MAO-A using fold recognition (threading) techniquesJ Wouters, E Depiereux, F Durant
Bioorganic & Medicinal Chemistry Letters|October 16, 1999
Antagonism of the TXA2 receptor by seratrodast: a structural approachJ Wouters, F Durant, B Masereel
Journal of Neurochemistry|July 14, 2006
Oligodendroglial metabotropic glutamate receptors are developmentally regulated and involved in the prevention of apoptosisKaren Luyt, Anikó Váradi, Claire F Durant, et al.
Journal of Theoretical Biology|August 21, 1987
3- and 5-isoxazolol zwitterions: an ab initio molecular orbital study relating to GABA agonism and antagonismT Boulanger, D P Vercauteren, F Durant, et al.
Biochemistry and Molecular Biology International|March 1, 1994
Kinetic characterization of tyramine oxidase of Arthrobacter speciesJ Wouters, P Perpète, P Hayen, et al.
Neurobiology (Budapest, Hungary)|September 29, 2000
Molecular interaction between reversible MAO-A inhibitors and the enzyme. Application to aryloxazolidinone, a prototype seriesF Ooms, S Jegham, P George, et al.
Bioorganic & Medicinal Chemistry|December 5, 1998
Molecular structure and stereoelectronic properties of sarmazenil--a weak inverse agonist at the omega modulatory sites (benzodiazepine receptors): comparison with bretazenil and flumazenilB López-Romero, G Evrard, F Durant, et al.
Journal of Computer-Aided Molecular Design|March 1, 1989
Structural requirements of Na+-dependent antidopaminergic agents: Tropapride, Piquindone, Zetidoline, and Metoclopramide. Comparison with Na+-independent ligandsS Collin, D P Vercauteren, D Vanderveken, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|July 15, 2009
Cutaneous infection by Alternaria infectoria in a renal transplant patientS Segner, F Jouret, J-F Durant, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Journal of Computer-Aided Molecular Design|February 1, 1996
Molecular modelling and conformational analysis of a GABAB antagonistB Pirard, F Durant
Neurobiology (Budapest, Hungary)|September 29, 2000
Structural approach of human MAO-A using fold recognition (threading) techniquesJ Wouters, E Depiereux, F Durant
Bioorganic & Medicinal Chemistry Letters|October 16, 1999
Antagonism of the TXA2 receptor by seratrodast: a structural approachJ Wouters, F Durant, B Masereel
Journal of Neurochemistry|July 14, 2006
Oligodendroglial metabotropic glutamate receptors are developmentally regulated and involved in the prevention of apoptosisKaren Luyt, Anikó Váradi, Claire F Durant, et al.
Journal of Theoretical Biology|August 21, 1987
3- and 5-isoxazolol zwitterions: an ab initio molecular orbital study relating to GABA agonism and antagonismT Boulanger, D P Vercauteren, F Durant, et al.
Biochemistry and Molecular Biology International|March 1, 1994
Kinetic characterization of tyramine oxidase of Arthrobacter speciesJ Wouters, P Perpète, P Hayen, et al.
Neurobiology (Budapest, Hungary)|September 29, 2000
Molecular interaction between reversible MAO-A inhibitors and the enzyme. Application to aryloxazolidinone, a prototype seriesF Ooms, S Jegham, P George, et al.
Bioorganic & Medicinal Chemistry|December 5, 1998
Molecular structure and stereoelectronic properties of sarmazenil--a weak inverse agonist at the omega modulatory sites (benzodiazepine receptors): comparison with bretazenil and flumazenilB López-Romero, G Evrard, F Durant, et al.
Journal of Computer-Aided Molecular Design|March 1, 1989
Structural requirements of Na+-dependent antidopaminergic agents: Tropapride, Piquindone, Zetidoline, and Metoclopramide. Comparison with Na+-independent ligandsS Collin, D P Vercauteren, D Vanderveken, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|July 15, 2009
Cutaneous infection by Alternaria infectoria in a renal transplant patientS Segner, F Jouret, J-F Durant, et al.
Pageof 4